International team develops potential COVID drug screening platform
04/30/2021 06:39 PM
To activate the text-to-speech service, please first agree to the privacy policy below.
Members of the research team pose for a group photo during a press event held Friday. CNA photo April 30, 2021
Taipei, April 30 (CNA) An international research team comprised of researchers from Taiwan and Malaysia has developed a platform where drugs with the potential to inhibit infection by the virus that causes COVID-19 can be identified from massive data banks of known medicines in about 20 minutes.
The platform for the rapid screening of SARS-CoV-2 inhibitors was developed as an efficient tool to sift through existing medicines and determine which are most likely to prove efficacious against COVID-19, the developers said at a press conference held by National Yang Ming Chiao Tung University (NYCU) in Taipei on Friday.